Researchers at the ICR and The Royal Marsden are planning to create a new generation of ‘anti-evolution’ therapies designed to combat cancer’s ability to adapt and resist treatment, as part of their new joint research strategy
Our biggest challenge is cancer evolution and drug resistance
Links
[1] https://www.cancerbrc.org/advance
[2] https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F289
[3] https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F289
[4] http://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F289
[5] https://plus.google.com/share?url=https%3A%2F%2Fwww.cancerbrc.org%2Fprint%2F289
[6] https://www.cancerbrc.org/advance/evolving-challenge
[7] https://www.royalmarsden.nhs.uk/our-research/research-strategy/making-discoveries-our-strategy-defeat-cancer